Global Sleep Apnea Devices Market share to exceed $8.5bn by 2023
Get more details @ http://bit.ly/2ozeW9w Some of the companies operating in sleep apnea devices market include Braebon Medical, Cadwell Laboratories, Carefusion, Compumedics, Philips Respironics and ResMed. Industry players are focusing on developing easy to use, portable and highly comfortable products.
Get more details @ http://bit.ly/2ozeW9w
Some of the companies operating in sleep apnea devices market include Braebon Medical, Cadwell Laboratories, Carefusion, Compumedics, Philips Respironics and ResMed. Industry players are focusing on developing easy to use, portable and highly comfortable products.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
this, attention <strong>to</strong>wards serious implication of this disorder on human health and<br />
promising reimbursement scenario will fuel the market growth.<br />
Germany sleep apnea devices market size, <strong>by</strong> product, 2012-<strong>2023</strong> (USD<br />
Million)<br />
Browse key industry insights spread across 105 pages with 38 market data tables &<br />
6 figures & charts from this 2017 report <strong>Sleep</strong> <strong>Apnea</strong> <strong>Devices</strong> <strong>Market</strong> in detail along<br />
with the table of contents at:<br />
https://www.gminsights.com/industry-analysis/sleep-apnea-devices-market-report<br />
Considering the regional outlook, below are the key highlights of sleep apnea<br />
devices market dynamics over 2016-<strong>2023</strong>:<br />
China sleep apnea devices market is expected <strong>to</strong> register <strong>to</strong> a CAGR of 11% from<br />
2016-<strong>2023</strong>. Increasing incidence of OSA coupled with the rising geriatric population<br />
will ignite the regional growth.<br />
Japan market, contributing more than 44% of the <strong>to</strong>tal regional revenue in 2015, is<br />
projected <strong>to</strong> witness heavy gains in the coming six years. Rising healthcare<br />
expenditure and the presence of the huge patient pool is likely <strong>to</strong> drive the demand<br />
for sleep apnea industry.<br />
U.S. sleep apnea devices industry is projected <strong>to</strong> register a CAGR of 7.5% over the<br />
span of 2016-<strong>2023</strong>. The regional growth can be attributed <strong>to</strong> favorable Medicare<br />
policies and deployment of advanced products in the region.<br />
UK sleep apnea devices industry is set <strong>to</strong> grow at a CAGR of 7% over 2016-<strong>2023</strong>.<br />
Favorable government initiatives in this regard will surge the industry growth.<br />
2 | P a g e
Change language